Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial – The Lancet Respiratory Medicine   Commentary on Twitter NEW Research—Brensocatib treatment did not improve clinical status at day 29 in patients hospitalised with #COVID19 Being presented at #ERSCongress, ALERT 3 session, Sept 5 from 13:15 BST From @profjdchalmers, @keirholly, […]

The post RCT | Dipeptidyl peptidase-1 inhibition does not improve outcomes in patients hospitalized with COVID-19. appeared first on Links Medicus.